LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

Search

NeoGenomics Inc

Closed

7.14

Overview

Share price change

24h

Current

Min

7.06

Max

7.31

Key metrics

By Trading Economics

Income

-11M

-26M

Sales

-4M

168M

EPS

-0.204

Profit margin

-15.427

Employees

2,200

EBITDA

-10M

-6.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+83.7% upside

Dividends

By Dow Jones

Next Earnings

28 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-382M

901M

Previous open

7.14

Previous close

7.14

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Jun 2025, 17:32 UTC

Major Market Movers

Lion Group Shares Climb on $600 Million Loan for Crypto Treasury

16 Jun 2025, 14:26 UTC

Acquisitions, Mergers, Takeovers

Crypto Group Tron to Go Public in U.S. Via Reverse Merger With SRM Entertainment

26 Jun 2025, 07:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26 Jun 2025, 07:11 UTC

Market Talk

Bitcoin Eases From Earlier Gains on Israel-Iran Cease-Fire -- Market Talk

25 Jun 2025, 12:33 UTC

Acquisitions, Mergers, Takeovers

Anthony Pompliano's ProCap BTC Buys Another 1,208 Bitcoin and Now Holds a Total of 4,932 Bitcoin

25 Jun 2025, 07:07 UTC

Market Talk

Bitcoin Rises as Israel-Iran Cease-fire Boosts Sentiment -- Market Talk

24 Jun 2025, 06:55 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics -2-

24 Jun 2025, 06:55 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

24 Jun 2025, 06:55 UTC

Market Talk

Bitcoin Rises on Israel-Iran Ceasefire News -- Market Talk

23 Jun 2025, 07:03 UTC

Market Talk

Bitcoin Recovers Slightly From Losses Due to U.S. Strikes Against Iran -- Market Talk

20 Jun 2025, 07:16 UTC

Market Talk

Bitcoin Rises as Risk Sentiment Improves -- Market Talk

19 Jun 2025, 07:37 UTC

Market Talk

Bitcoin Trades Steady Amid Investor Caution Over Israel-Iran Conflict -- Market Talk

18 Jun 2025, 13:32 UTC

Market Talk

Stablecoin Bill Could Extend Dollar's Global Dominance -- Market Talk

18 Jun 2025, 07:25 UTC

Market Talk

Bitcoin Edges Higher After Senate Passes Stablecoin Bill -- Market Talk

17 Jun 2025, 22:14 UTC

Major Market Movers

Bitdeer Technologies Group Shares Fall on Note Offering

17 Jun 2025, 06:57 UTC

Market Talk

Bitcoin Falls as Israel-Iran Conflict Dents Risk Appetite -- Market Talk

17 Jun 2025, 06:57 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 Jun 2025, 08:28 UTC

Market Talk
Earnings

Swissquote Faces Weaker Trading, Crypto Outlook -- Market Talk

16 Jun 2025, 07:14 UTC

Market Talk

Bitcoin Recovers From Losses Driven by Middle East Tensions -- Market Talk

13 Jun 2025, 05:55 UTC

Market Talk

Bitcoin Bears Take Lead as Israel-Iran News Drags Crypto -- Market Talk

13 Jun 2025, 02:21 UTC

Market Talk

Bitcoin Tumbles as Israel Attack on Iran Sparks Risk Selloff -- Market Talk

12 Jun 2025, 11:35 UTC

Market Talk

Weaker Dollar Could Help Bitcoin Rise Again -- Market Talk

12 Jun 2025, 08:41 UTC

Market Talk

Bitcoin Falls as Trade, Geopolitical Worries Grow -- Market Talk

11 Jun 2025, 16:26 UTC

Acquisitions, Mergers, Takeovers

MicroStrategy's Preferred Yields 11% as Trading Starts. The CEO Bought Shares. -- Barrons.com

11 Jun 2025, 12:08 UTC

Market Talk

Bitcoin Falls, Stays Stuck Below $110,000 -- Market Talk

10 Jun 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Jun 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Jun 2025, 12:29 UTC

Market Talk

Bitcoin Could Work as a Hedge Against Inflation -- Market Talk

9 Jun 2025, 08:38 UTC

Market Talk

Bitcoin Falls as Investors Stay Cautious -- Market Talk

6 Jun 2025, 14:28 UTC

Market Talk

Bitcoin Rises After Above-Forecast U.S. Jobs Data -- Market Talk

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

83.7% upside

12 Months Forecast

Average 13.19 USD  83.7%

High 26 USD

Low 8.5 USD

Based on 12 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

7

Buy

5

Hold

0

Sell

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.